SATB2 and head and neck squamous cell carcinoma: To date, the role of SATB2 in chemotherapy response has only been investigated in one study on head and neck squamous cell carcinoma (HNSCC) cells, where SATB2 was demonstrated to promote chemo- and radiation resistance by modulation of ΔNp63 (Chung et al, 2010).